[1]
2025. Comparison of the GLP-1 Receptor Agonists with other anti-obesity/anti-diabetic medicines: a systematic review. Review Journal of Neurological & Medical Sciences Review. 3, 5 (Sep. 2025), 347–368. DOI:https://doi.org/10.63075/w16p9p55.